SIM
CRBP icon

Spark Investment Management’s Corbus Pharmaceuticals CRBP Stock Holding History

Spark Investment Management’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-4,327
Closed -$214K – 778
2015
Q4 		$214K Buy
4,327
+2,774
+179% +$141K 0.03% 568
2015
Q3 		$71K Buy
+1,553
New +$103K 0.01% 627

Other funds holding CRBP

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
YP
Yellowstone Partners Idaho Falls, Idaho $177M AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Spark Investment Management's CRBP Position: Q1 2016 in Review

Spark Investment Management sold out of Corbus Pharmaceuticals (CRBP) in Q1 2016, closing a stake of 4,327 shares — an estimated $214K sold.

Spark Investment Management first reported a position in CRBP in Q3 2015 and held it in 2 quarters. The position peaked at $214K in Q4 2015. 22 funds tracked by Wall St. Rank hold CRBP as of Q1 2016.

  • Spark Investment Management reported no remaining Corbus Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Spark Investment Management sold 4,327 Corbus Pharmaceuticals shares in Q1 2016, an estimated $214K.
  • Spark Investment Management first reported a position in Corbus Pharmaceuticals in Q3 2015 and held it in 2 quarters.
  • Spark Investment Management's Corbus Pharmaceuticals position peaked at $214K in Q4 2015.
  • 22 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2016.

Based on Spark Investment Management's 13F filing for Q1 2016, filed 12 May 2016.